Sheldon Kenton appointed Managing Director, Bupa Global
Sheldon Kenton
By

(Press Release) 21 September 2016] Bupa Global, the international health insurance arm of Bupa, is pleased to announce the appointment of Sheldon Kenton to Managing Director, subject to regulatory approval. Sheldon will take over responsibilities from Robert Lang, who was recently appointed Managing Director of Bupa’s International Markets business.

 Robert Lang, Managing Director, Bupa International Markets, said: “Sheldon is an experienced and well-established leader across the global insurance sector, with tremendous knowledge of the IPMI market. He has a clear understanding of Bupa Global’s strategy and priorities and will lead day-to-day operations setting the strategic direction for Bupa Global to drive growth and deliver outstanding customer service.”

 Sheldon joined Bupa Global in December 2015 as Global Commercial Director after 18 years with Cigna and was responsible for growing Bupa Global’s corporate sales and health benefits business. Since he joined, Bupa Global has seen record new business performance in the corporate segment, year to date.

 Sheldon Kenton, Managing Director, Bupa Global, said: “I’m really pleased to be taking on this new role and leading Bupa Global in this exciting next chapter of its journey. I am committed to delivering on our strategy, of establishing our new regions and transforming our customer services offering. Together, this will provide our customers and clients with the most premium level of service in their own language, culture and time zone.”

 This announcement follows the creation of Bupa International Markets which brings together Bupa Global , Bupa Arabia, Max Bupa in India and Bupa’s domestic businesses   Bupa Hong Kong, Quality HealthCare, Bupa China and Bupa Thailand. This will enable them to fully leverage the unique international capabilities that our Bupa Global offering brings. Bupa Global will also benefit by accessing Bupa’s in-market licenses and networks

Recommend to friends

Leave a comment